Answers are grounded in this paper and cite their sources.
Several 5,8-bis[(aminoalkyl)amino]-1-azaanthracene-9,10-diones have been synthesized and evaluated for antitumor activity against L1210 leukemia both in vitro and in vivo. Comparisons are made to the corresponding carbocyclic analogues. One of the aza analogues showed modest in vivo activity.
No takes yet. Share an insight, caveat, or question.
Krapcho et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: